lithium has been researched along with ritanserin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jope, RS; Williams, MB | 1 |
| Akhondzadeh, S; Amini, H; Mohajari, H; Reza Mohammadi, M | 1 |
1 trial(s) available for lithium and ritanserin
| Article | Year |
|---|---|
Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.
Topics: Acute Disease; Adult; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Placebos; Ritanserin; Serotonin; Serotonin Antagonists; Treatment Outcome | 2003 |
1 other study(ies) available for lithium and ritanserin
| Article | Year |
|---|---|
Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo.
Topics: Amphetamines; Animals; Drug Synergism; Genes, fos; Lithium; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Ritanserin; Seizures; Serotonin Receptor Agonists; Stereoisomerism; Stimulation, Chemical | 1994 |